Immunome Inc IMNMNasdaq
25.69USDClose on 08/10
At a glance
Immunome Inc sits in the ‘Resting’ stage of its cycle. It has moved +2.5% since its first surge signal on 2026-01-29, when the past-year gain stood at +171.3%.
- Since surge signal
- +2.5%
- First surge signal
- 2026-01-29
- Price at signal
- 25.07
- Past-year gain (at signal)
- +171.3%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.